Metrics as of 10/17/2026, 07:37 AM (Berlin time), refresh in progress.
Eli Lilly and Company Stock
Eli Lilly and Company
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- United States
- CEO
- David A. Ricks
- Employees
- 50,000
- Market cap
- $1.55 T
- IPO
- 22/12/2025
Eli Lilly and Company is a company operating in the Healthcare sector as a Drug Manufacturers - General firm. Headquartered in Indianapolis, the company employs approximately 50,000 employees. The business model focuses on the discovery, development, manufacture, and sale of pharmaceutical products. The product…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Eli Lilly and Company stock: price history
1D
+0.5%
1W
+6.8%
1M
+10.3%
6M
+34.2%
YTD
+14.8%
1Y
–
2Y
–
5Y
–
10Y
–
Pattern chart
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Eli Lilly and Company
Free float & liquidity
FREE FLOAT
–
FLOAT SHARES
–
AVG. DAILY VOLUME (30D)
89,538
Dividends
Comparable stocks
Frequently asked questions about Eli Lilly and Company stock
What does Eli Lilly and Company do?
Eli Lilly and Company is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in United States.
The CEO is David A. Ricks, the company employs around 50,000 people.
The IPO was on 22/12/2025; the stock trades on TSX under the ticker LLY.TO.
Does Eli Lilly and Company pay a dividend?
Yes. The last dividend was CA$0.06 per share, ex-date 14/08/2026, paid on 17/09/2026.
Which stocks are comparable to Eli Lilly and Company?
Comparable stocks include Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Amgen, Gilead Sciences, Pfizer and Bristol-Myers Squibb Company.
How can I get Eli Lilly and Company stock analyzed?
Clicking "Analyze stock" lets five strategies assess Eli Lilly and Company against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.